These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12651282)

  • 1. Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).
    Bocchia M; Gentili S; Forconi F; le Noci M; Tozzi M; Lauria F
    Haematologica; 2003 Mar; 88(3):358-60. PubMed ID: 12651282
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
    Fabbri A; Lenoci M; Gozzetti A; Chitarrelli I; Olcese F; Raspadori D; Gobbi M; Lauria F
    Br J Haematol; 2007 Oct; 139(1):90-3. PubMed ID: 17854311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Millenson MM; Roboz GJ; Honeycutt C; Thune R; Padavic-Shaller K; Carter WH; Ramakrishnan V; Murgo AJ; Grant S
    Clin Cancer Res; 2006 Oct; 12(19):5809-16. PubMed ID: 17020988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
    Czuczman MS; Koryzna A; Mohr A; Stewart C; Donohue K; Blumenson L; Bernstein ZP; McCarthy P; Alam A; Hernandez-Ilizaliturri F; Skipper M; Brown K; Chanan-Khan A; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-Lopez A; Bernstein SH
    J Clin Oncol; 2005 Feb; 23(4):694-704. PubMed ID: 15681517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
    Velasquez WS; Lew D; Grogan TM; Spiridonidis CH; Balcerzak SP; Dakhil SR; Miller TP; Lanier KS; Chapman RA; Fisher RI;
    J Clin Oncol; 2003 May; 21(10):1996-2003. PubMed ID: 12743154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
    Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
    Alliot C
    J Clin Oncol; 2003 Jul; 21(13):2626; author reply 2626-7. PubMed ID: 12829689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Tikhonova VV
    Vopr Onkol; 2004; 50(5):602-4. PubMed ID: 15715106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of low grade and intermediate grade non-Hodgkin's lymphomas with intensive combination chemotherapy.
    Bolaman Z; Sentürk T; Kadköylü G
    Haematologica; 1999; 84(E-letters):E03. PubMed ID: 11084661
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
    Trojan A; Meier R; Licht A; Taverna C
    Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].
    Huang HQ; Jiang WQ; Peng YL; Xia ZJ; Li YH; Li XB; Lin TY; Sun XF; Guan ZZ
    Ai Zheng; 2004 Apr; 23(4):448-51. PubMed ID: 15087037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA).
    Caracciolo F; Capochiani E; Papineschi F; Petrini M
    Hematol Oncol; 1997 Feb; 15(1):27-31. PubMed ID: 9378469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
    Tam CS; Wolf MM; Januszewicz EH; Prince HM; Westerman D; Seymour JF
    Cancer; 2004 May; 100(10):2181-9. PubMed ID: 15139062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas.
    Eucker J; Schille C; Schmid P; Jakob C; Schetelig J; Kingreen D; Mergenthaler HG; Huhn D; Possinger K; Sezer O
    Anticancer Drugs; 2002 Oct; 13(9):907-13. PubMed ID: 12394253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
    Dimopoulos MA; Fountzilas G; Papageorgiou E; Kiamouris C; Mantzios G; Anagnostopoulos A; Nicolaides C; Economopoulos T;
    Leuk Lymphoma; 2002 Jan; 43(1):111-4. PubMed ID: 11908713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
    Abbasi MR; Sparano JA; Sarta C; Wiernik PH
    Med Oncol; 2003; 20(1):53-8. PubMed ID: 12665685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
    Hogan WJ; Edwards WD; Macon WR; Habermann TM
    Leuk Lymphoma; 2001; 42(5):1145-50. PubMed ID: 11697635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
    Addeo R; Caraglia M; Costanzo R; Faiola V; Montella L; Abbruzzese A; Del Prete S
    Oncol Rep; 2004 Jul; 12(1):135-40. PubMed ID: 15201974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
    J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.